secwatch.observer — SEC 8-K summary
======================================

Issuer:     Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
CIK:        0001757499
Form:       8-K
Filed at:   2023-06-05T23:59:59+00:00
Accession:  0001493152-23-020084
Event type: debt
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shuttle Pharma releases $2.924M cash collateral from Alto note; ends controlled account restriction
--------------------------------------------------------------------------------

- Alto releases remaining $2.924M cash collateral to the company, no longer held in controlled account.
- Section 15(q) of the convertible note is deemed inapplicable; company free to use funds for general business.
- If Alto exercises option for up to $10M in additional notes, those notes will also omit controlled account provisions.
- Company pays $2,750 for holder's expenses; no event of default acknowledged.
- Company agrees to file Form 8-K disclosing material terms by next trading day.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1757499/000149315223020084/0001493152-23-020084-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1757499/000149315223020084/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-020084

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer